Research programme: thrombopoietin variants - Xencor

Drug Profile

Research programme: thrombopoietin variants - Xencor

Alternative Names: Thrombopoietin; TPO variants

Latest Information Update: 17 Apr 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Xencor
  • Class Colony-stimulating factors; Glycoproteins
  • Mechanism of Action Thrombopoietin stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Thrombocytopenia

Most Recent Events

  • 17 Apr 2006 Discontinued - Preclinical for Thrombocytopenia in USA (unspecified route)
  • 22 Aug 2003 Preclinical trials in Thrombocytopenia in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top